Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001628280-26-046702
Filing Date
2026-07-02
Accepted
2026-07-02 08:30:37
Documents
84
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A pre-20251231.htm   iXBRL 20-F/A 738499
2 EX-12.1 ex121ceo.htm EX-12.1 9696
3 EX-12.2 ex122cfo.htm EX-12.2 9701
4 EX-13.1 ex131ceo.htm EX-13.1 3059
5 EX-13.2 ex132cfo.htm EX-13.2 3304
6 EX-15.1 ex151consentofdeloitte-20fa.htm EX-15.1 2298
  Complete submission text file 0001628280-26-046702.txt   4970781

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pre-20251231.xsd EX-101.SCH 52049
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pre-20251231_cal.xml EX-101.CAL 60583
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pre-20251231_def.xml EX-101.DEF 152853
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pre-20251231_lab.xml EX-101.LAB 437776
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pre-20251231_pre.xml EX-101.PRE 302459
88 EXTRACTED XBRL INSTANCE DOCUMENT pre-20251231_htm.xml XML 883698
Mailing Address 7/F, K11 ATELIER, 728 KING'S ROAD QUARRY BAY K3 000000
Business Address 7/F, K11 ATELIER, 728 KING'S ROAD QUARRY BAY K3 000000 (852) 2210-7188
Prenetics Global Ltd (Filer) CIK: 0001876431 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-41401 | Film No.: 261147834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)